CSIMarket Company Name, Ticker, Suppliers, else..
 
Creative Medical Technology Holdings Inc   (NASDAQ: CELZ)
Other Ticker:  
 
 
Price: $2.4500 $0.00 0.000%
Day's High: $2.53 Week Perf: -8.92 %
Day's Low: $ 2.35 30 Day Perf: -39.05 %
Volume (M): 42 52 Wk High: $ 10.28
Volume (M$): $ 102 52 Wk Avg: $4.04
Open: $2.50 52 Wk Low: $2.21



 Market Capitalization (Millions $) 3
 Shares Outstanding (Millions) 1
 Employees 11
 Revenues (TTM) (Millions $) -
 Net Income (TTM) (Millions $) -5
 Cash Flow (TTM) (Millions $) 2
 Capital Exp. (TTM) (Millions $) 0

Creative Medical Technology Holdings Inc
Creative Medical Technology Holdings Inc. is a biotechnology company that focuses on developing and commercializing stem cell-based therapies and products to treat various medical conditions. The company's innovative approach involves using stem cells derived from the patient's own adipose tissue to develop personalized treatments. The therapies are aimed at addressing conditions like erectile dysfunction, immune system disorders, and degenerative conditions of the spine, among others. Creative Medical Technology Holdings Inc. aims to bring much-needed advancements in regenerative medicine to improve patient outcomes and quality of life.


   Company Address: 211 E Osborn Road Phoenix 85012 AZ
   Company Phone Number: 399-2822   Stock Exchange / Ticker: NASDAQ CELZ


   

Stock Performances by Major Competitors

5 Days Decrease / Increase
     
BCRX        2.6% 
IOVA        2.6% 
HSDT        2.6% 
NVCT        2.6% 
RIGL   -9.5%    
• View Complete Report
   



Clinical Study

Innovative Regenerative Approach Medical Technologys Breakthrough in Chronic Lower Back Pain Treatment

Published Wed, Nov 13 2024 2:00 PM UTC

In an exciting advancement for the field of regenerative medicine, Creative Medical Technology Holdings, Inc. (NASDAQ: CELZ) has announced a significant milestone in its ADAPT clinical trial. As of November 13, 2024, the independent Data Safety Monitoring Board (DSMB) has successfully completed an interim safety review, affirming the safety and potential efficacy of CELZ-201...
Shares

Medical Technology Holdings Announces $1.85 Million Share Offering to Enhance Immunotherapy Initiatives

Published Wed, Oct 23 2024 12:01 PM UTC

In a strategic move to bolster its innovative healthcare initiatives, Creative Medical Technology Holdings, Inc. (NASDAQ: CELZ), announced on October 23, 2024, that it has successfully entered into definitive securities purchase agreements with institutional investors for a registered direct offering of common stock. The deal amounts to approximately $1.85 million, with the ...
Product Service News

Medical Technology Holdings Advances AI-Driven Diagnostic and Treatment Program for Biologic and Chemical Exposure

Published Wed, Jul 24 2024 1:01 PM UTC

Creative Medical Technology Holdings, Inc. (NASDAQ: CELZ), an innovative biotechnology company specializing in regenerative therapies, has recently embarked on a groundbreaking initiative. The company announced the development of an AI-driven diagnostic and treatment program designed to aid patients exposed to biological and chemical weapons. By combining Artificial Intellig...
Management Announcement

Medical Technology Holdings Shows Positive Stock Growth Despite Recent Losses

Published Wed, Jul 10 2024 12:31 PM UTC

Medical Technology Holdings Inc has been making strides within the healthcare sector, progressing from a total return on investment (ROI) ranking of 2927 in the fourth quarter of 2023 to 2767 in the Mar 31, 2024, quarter. Although the current ROI stands at -46.49%, 351 other companies within the healthcare sector have achieved a higher ROI.
Despite the negative ROI, Cre...
Clinical Study

Medical Technology Pioneers Revolutionary Solution to Diabetes Treatment by Generating iPSC-Derived Islet Cells that ...

Published Mon, Jun 24 2024 12:30 PM UTC

Creative Medical Technology Announces Breakthrough in iPSCelz Program: Successful Generation of Human Insulin-Producing Islet CellsCreative Medical Technology Holdings, a prominent biotechnology company specializing in regenerative approaches to immunotherapy, urology, neurology, and orthopedics, has recently achieved a remarkable development in its iPSCelz program. The com...









Help

About us

Advertise
CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2024 CSIMarket, Inc. All rights reserved.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com